Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | 240561 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | 390652 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | 411846 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | Peak area normalized | female | diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | Peak area normalized | female | diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | Peak area normalized | female | normoglycemic | Neuropathy | |
Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | Peak area normalized | male | diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | Peak area normalized | male | diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | Peak area normalized | male | pre-diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | Peak area normalized | male | pre-diabetic | no neuropathy |